 Life Science Investor Mandates
(June 1
- June 7)
|
|
|
|
|
Invests in Commercial Stage Devices and Renal Drugs
|
Seeks to Expands Pipeline in Oncology, Rare Diseases and Neuro Therapeutics
|
|
Invests in Clinical Stage Pharmaceuticals, Medical Devices and Diagnostics
|
|
Focuses On Women's Health, Research Tools, Immunotherapy and Diagnostics
|
|
Click to see investors that are a fit for your product and stage of development
|
|
Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you
|
|
Click here if you want to receive free, targeted early stage dealflow for your life science investment firm
|
|
|
By
Nono Hu, Director of Marketing, LSN
 With 10 days to go until the first RESI San Diego event, LSN is proud to present the latest RESI program guide. If you want to see the full lineup of sponsors, investor panelists, RESI Innovators and speakers, you're in the right place. RESI San Diego will bring together hundreds of active investors and early stage startups to begin their BIO week with a dedicated day of partnering, networking, and early stage-focused content. Check out the details below.
|
 |
By
Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series
 Life Science Nation (LSN) and Johnson and Johnson Innovation, JLABS have launched San Diego's first Redefining Early Stage Investments (RESI) Conference on June 19th, 2017 during the 2017 BIO week when the biotech and medtech world gathers in San Diego. RESI San Diego will bring together 400+ fundraising CEOs and 400+ early stage investors (a 1:1 ratio) from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.
|
|
 RESI is a venue where early stage life science startups can meet with investors of every type that are a fit for their company's technology and stage - and that includes family offices. RESI San Diego features two panels devoted to this elusive investor class - Biotech Family Offices and Medtech Family Offices. Whether you're developing a novel therapeutic, an innovative device or an improved diagnostic solution, Family Offices can't be overlooked as a potential source of capital and RESI will provide you with the opportunity to hear advice and insight directly from key investment decision makers from family offices.
Biotech Family Offices, moderated by
Colin Widen (CEO, Boston Innovation Capital), features:
- Jayson Rieger (SVP of Business Development & Portfolio Management, PBM Capital Group)
- Craig Philips (Partner, Whetstone Ventures)
- Sergei Petukhov (Partner, Enso Ventures)
- Chuck Stetson (CEO, Stetson Family Office)
Medtech Family Offices, moderated by
Michael Quigley (VP of Market Research, Life Science Nation), features:
- Sean Kearney (Managing Director, Three Leaf Ventures)
- Julia Belaya (Director - Corporate Partnerships, Plug and Play Tech Center)
- John Kinzell (Senior Life Science Analyst, The McNair Group)
- Kyle Williams (President, Bootstrap Incubation)
|
|
|
|
|
|
|
